In a change of position, the U.S. Preventative Services Taskforce has reversed its earlier recommendation against PSA screening, to now recommend that men aged 55-69 make an individual decision about prostate cancer screening with their clinicians but recommends against routine screening for men age 70 and older. The new recommendation is based on new evidence that shows there are now more options, and therefore more information available to clinicians and patients when deciding whether or not to undergo treatment. The adoption of more Active Surveillance, better MRI imaging capability in the diagnostic process and a growing understanding of the disease have all contributed to this new decision, which is largely in line with the New Zealand Guidelines published in 2015. Read the  LA Times story about this decision, see the U.S. Recommendation here. Watch this CBS news piece.